三星医疗(601567) - 三星医疗投资者关系活动记录表(2024年6月)
SANXINGSANXING(SH:601567)2024-07-01 08:31

Group 1: Financial Performance - The company's order amount for Q1 2024 is 12.462 billion [1] - Revenue for 2023 shows a year-on-year increase of 33.18%, with domestic revenue at 6.963 billion (up 18.45%) and overseas revenue at 5.499 billion (up 58.07%) [2] - The company is experiencing stable growth in the domestic electricity demand, with a focus on smart electricity meters and distribution equipment [2] Group 2: Market Expansion - The company is actively expanding in Europe, the Middle East, Latin America, and Asia-Pacific, with new production bases in Germany and Mexico [1] - Successful delivery of multiple AMI projects overseas, including the PUMA smart meter project in Sweden with a collection rate exceeding 99.9% [2] - The company plans to increase its self-built hospital ratio as part of its medical strategy, aiming to add 10 hospitals annually through self-construction and acquisition [3] Group 3: Strategic Initiatives - The company is transitioning to an integrated project model to enhance customer loyalty [1] - There is a focus on diversifying channels and products to improve operational capabilities and market share [2] - The company anticipates increased investment in distribution networks following supportive government policies [2]